| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca32fd2a44fd326ffd027a75a57bd13f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-55 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2000-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_492ab953e219854ba8f50de155b471ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfaf8ff3927c6526650982f6305a96c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5ac852110deaa7c36bc87ff11a58bd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ec8d030c8c3778afbe85e9753e8f7da |
| publicationDate |
2003-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6596853-B1 |
| titleOfInvention |
DNA encoding peptides of IL-2 |
| abstract |
The invention relates to the use as therapeutic agents of IL-2 peptides and derivatives having biological activity and anti-IL-2 antibodies which mimic or modulate the biological activities of IL-2. The invention also relates to DNA sequences encoding the IL-2 peptides, and to methods of using the IL-2 peptides and derivatives and anti-IL-2 antibodies to modulate or mimic or antagonize the biological activities of IL-2 in vivo and to assay for the presence and activity of the IL-2 receptor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11491205-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007048302-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7662368-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7704490-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11083778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004202661-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943294-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9513298-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372581-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7101965-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006024723-A1 |
| priorityDate |
1998-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |